)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Ekso Bionics (EKSO) investor relations material
Ekso Bionics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary28 Jul, 2025
Executive summary
Q2 2025 revenue declined sharply to $2.1M, mainly due to delayed Enterprise Health sales, partially offset by strong growth in Personal Health products.
Net loss for Q2 2025 was $2.7M ($1.24/share), up from $2.4M ($1.99/share) in Q2 2024.
Gross margin declined to 40% from 53% year-over-year, impacted by lower Enterprise Health sales and higher shipping costs.
Management remains confident in closing deferred sales and returning to growth in the second half of 2025, with a focus on expanding personal health and integrating AI capabilities.
Company launched new AI initiatives, including the Ekso Voice Agent, and expanded educational offerings with eksoUniversity.
Financial highlights
Q2 2025 revenue: $2.1M (Q2 2024: $5.0M); gross profit: $0.8M (40% margin) vs. $2.6M (53% margin) year-over-year.
Net loss: $2.7M ($1.24/share) vs. $2.4M ($1.99/share) in Q2 2024.
Cash and restricted cash at June 30, 2025: $5.2M.
Operating expenses improved 4% to $4.8M from $5.0M in Q2 2024; G&A increased due to lower allocable manufacturing costs and an intangible asset impairment.
Working capital at June 30, 2025: $9.3M (Dec 31, 2024: $11.3M).
Outlook and guidance
Deferred enterprise health sales of $1.4M expected to close in 2025, with $1M likely in Q3.
Personal health product revenue projected to reach 25% of total revenue in 2025, up from 10% in 2024.
Management expects to recover deferred Enterprise Health sales in the second half of 2025 and anticipates continued strong growth from Personal Health products.
Additional financing is being sought to meet cash requirements for the next 12 months; failure to secure funding may require cost reductions or curtailment of development projects.
Unrestricted cash projected to fund operations into Q4 2025.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Ekso Bionics earnings date
Q3 202527 Oct, 2025
Next Ekso Bionics earnings date
Q3 202527 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Ekso Bionics Holdings Inc. is a company that develops and manufactures wearable exoskeletons designed to enhance human mobility and strength. Its core products include robotic exoskeletons used in rehabilitation and industrial applications. In healthcare, Ekso Bionics provides solutions that help patients with neurological conditions or injuries to regain mobility through assisted walking. The company's exoskeletons are also used in industrial settings to reduce worker fatigue and prevent injuries by augmenting human strength and endurance during heavy lifting and repetitive tasks. The company is headquartered in Richmond, California, USA, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage